Acute Myeloid Leukemia (AML) -Choosing Wisely: Upfront Treatment Intensity Selection in Adults with AML - Intensive Chemotherapy in Younger Adults
9:45 AM - 10:00 AM HST
Yes, I Integrate Novel Therapies with Intensive Chemotherapy
Presenter: Tapan M. Kadia, MD – The University of Texas MD Anderson Cancer Center
10:00 AM - 10:15 AM HST
Acute Myeloid Leukemia (AML) -Choosing Wisely: Upfront Treatment Intensity Selection in Adults with AML - Intensive Chemotherapy in Younger Adults
10:00 AM - 10:15 AM HST
No, It is Prime Time for Upfront Lower Intensity Triplet Therapies
Presenter: Eunice S. Wang, MD – Roswell Park Comprehensive Cancer Center
10:50 AM - 11:05 AM HST
Acute Myeloid Leukemia (AML) - Debate/Discussion: Treatment Options for Relapsed or Refractory (R/R) AML
10:50 AM - 11:05 AM HST
Targeted Therapies in R/R AML
Presenter: Uma Borate, MD, MBBS – The Ohio State University Comprehensive Cancer Center
10:50 AM - 11:50 AM HST
Acute Myeloid Leukemia (AML) - Debate/Discussion: Treatment Options for Relapsed or Refractory (R/R) AML
10:50 AM - 11:50 AM HST
Moderator
Moderator: Joann B. Sweasy, MD (she/her/hers) – Fred and Pamela Buffett Cancer Center; Eppley Institute for Cancer Research, University of Nebraska Medical Center
Moderator: Geoffrey L. Uy, MD – Washington University School of Medicine
11:05 AM - 11:20 AM HST
Acute Myeloid Leukemia (AML) - Debate/Discussion: Treatment Options for Relapsed or Refractory (R/R) AML
11:05 AM - 11:20 AM HST
Targeted Radiotherapies and Other Novel Therapies in R/R AML
Presenter: Geoffrey L. Uy, MD – Washington University School of Medicine
11:20 AM - 11:35 AM HST
Acute Myeloid Leukemia (AML) - Debate/Discussion: Treatment Options for Relapsed or Refractory (R/R) AML